In:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Wiley, Vol. 37, No. 9 ( 2017-09), p. 990-999
Abstract:
Increased use of pharmacogenomic ( PG x) testing in the clinical setting has revealed a number of challenges to providing this service. PG x is an important component of precision medicine that brings together the fields of genetics and clinical pharmacology. A model that incorporates a multidisciplinary approach to implementation and information delivery may be the most beneficial to patients and providers. In this review, translational considerations in the provision of PG x testing and counseling services are described. Specifically, we report on the selection of PG x tests, the provision of patient education and counseling, and examples of PG x service delivery models that incorporate counseling by pharmacists and genetic counselors. Examples of ancillary risks associated with PG x testing, testing of children, and familial implications of testing are reviewed. Through multispecialty partnerships, including genetic counselors and pharmacists, implementation obstacles to PG x testing can be overcome to provide quality precision medicine to patients.
Type of Medium:
Online Resource
ISSN:
0277-0008
,
1875-9114
DOI:
10.1002/phar.2017.37.issue-9
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
2061167-5
SSG:
15,3
